Skip to main content

SPHERA FUNDS MANAGEMENT LTD.

Position in MRK — Merck & Co., Inc.

CIK 1496201 TEL AVIV, L3

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,530,100
+$1,684,006 QoQ
Shares Held
58,600
+20.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#854
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Jun 30, 2021
CallValue
$0
CallShares
0
PutValue
$60,085,102
PutShares
772,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $104,911,681 across 12 Drug Manufacturers - General names. MRK ranks #7 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 MRK
Merck & Co., Inc.
This page
58,600 $7,530,100

All Filings in MRK

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,530,100 58,600
2026-03-31 $5,846,094 48,600
2025-12-31 $5,115,636 48,600
2025-09-30 $4,078,998 48,600
2025-06-30 $3,847,176 48,600
2025-03-31 $5,349,696 59,600
2024-12-31 $5,929,008 59,600
2024-09-30 $6,768,176 59,600
2024-06-30 $7,378,480 59,600
2024-03-31 $13,670,020 103,600
2023-12-31 $13,474,872 123,600
2023-09-30 $12,724,620 123,600
2023-06-30 $13,916,034 120,600
2023-03-31 $12,830,634 120,600
2022-12-31 $13,380,570 120,600
2022-09-30 $31,606,040 367,000
2022-06-30 $25,983,450 285,000
2022-03-31 $22,826,310 278,200
2021-12-31 $26,549,858 346,423
2021-06-30 $60,085,102 772,600
2021-06-30 $60,085,179 772,601
2021-03-31 $62,351,042 808,808
2020-12-31 $59,616,467 728,808
2020-12-31 $10,633,995 130,000
2020-09-30 $73,311,907 883,808
2020-06-30 $60,611,898 783,808
2020-03-31 $66,823,747 868,518